Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 27 | 2026 | 137 | 6.850 |
Why?
|
| Cognition | 21 | 2026 | 90 | 4.580 |
Why?
|
| Cognitive Dysfunction | 16 | 2026 | 61 | 2.990 |
Why?
|
| Depression | 16 | 2026 | 479 | 2.550 |
Why?
|
| Stroke | 10 | 2025 | 297 | 2.410 |
Why?
|
| Aged, 80 and over | 44 | 2026 | 1887 | 2.200 |
Why?
|
| Aging | 10 | 2026 | 146 | 2.110 |
Why?
|
| Healthy Aging | 7 | 2026 | 11 | 2.090 |
Why?
|
| Neuropsychological Tests | 14 | 2026 | 47 | 2.050 |
Why?
|
| Schools | 4 | 2026 | 91 | 2.020 |
Why?
|
| Male | 73 | 2026 | 9556 | 2.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2026 | 116 | 1.980 |
Why?
|
| Female | 81 | 2026 | 12193 | 1.920 |
Why?
|
| Educational Status | 5 | 2025 | 163 | 1.820 |
Why?
|
| Humans | 96 | 2026 | 16832 | 1.800 |
Why?
|
| Executive Function | 13 | 2026 | 29 | 1.800 |
Why?
|
| Aged | 56 | 2026 | 5901 | 1.790 |
Why?
|
| Brain | 5 | 2026 | 47 | 1.780 |
Why?
|
| Cohort Studies | 35 | 2026 | 2396 | 1.550 |
Why?
|
| Memory, Episodic | 11 | 2026 | 12 | 1.460 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2019 | 70 | 1.450 |
Why?
|
| Risk Factors | 32 | 2026 | 3108 | 1.390 |
Why?
|
| Middle Aged | 47 | 2026 | 7515 | 1.300 |
Why?
|
| Longitudinal Studies | 21 | 2026 | 653 | 1.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2025 | 677 | 1.070 |
Why?
|
| Hypertension | 6 | 2026 | 475 | 1.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2025 | 155 | 0.960 |
Why?
|
| Longevity | 7 | 2026 | 14 | 0.920 |
Why?
|
| Incidence | 17 | 2026 | 1229 | 0.860 |
Why?
|
| Alzheimer Disease | 4 | 2026 | 51 | 0.860 |
Why?
|
| California | 17 | 2026 | 2244 | 0.790 |
Why?
|
| Stress, Psychological | 4 | 2019 | 136 | 0.780 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2026 | 107 | 0.750 |
Why?
|
| Residence Characteristics | 5 | 2024 | 244 | 0.740 |
Why?
|
| Cardiovascular Diseases | 6 | 2018 | 520 | 0.730 |
Why?
|
| Proportional Hazards Models | 12 | 2025 | 657 | 0.710 |
Why?
|
| Machine Learning | 4 | 2026 | 60 | 0.700 |
Why?
|
| African Americans | 5 | 2021 | 394 | 0.660 |
Why?
|
| Hypoglycemia | 2 | 2019 | 48 | 0.660 |
Why?
|
| Health Status | 2 | 2026 | 256 | 0.640 |
Why?
|
| United States | 16 | 2026 | 3858 | 0.620 |
Why?
|
| Sleep | 1 | 2020 | 54 | 0.600 |
Why?
|
| Sex Factors | 6 | 2026 | 560 | 0.530 |
Why?
|
| Prospective Studies | 12 | 2026 | 1186 | 0.530 |
Why?
|
| Continental Population Groups | 1 | 2019 | 255 | 0.530 |
Why?
|
| Adult | 19 | 2025 | 7255 | 0.520 |
Why?
|
| Sex Characteristics | 1 | 2017 | 58 | 0.520 |
Why?
|
| Apolipoprotein E4 | 2 | 2026 | 5 | 0.490 |
Why?
|
| Hippocampus | 2 | 2025 | 8 | 0.450 |
Why?
|
| Social Class | 4 | 2026 | 106 | 0.430 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 215 | 0.430 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 1058 | 0.410 |
Why?
|
| Life Style | 2 | 2026 | 305 | 0.400 |
Why?
|
| Neuroimaging | 4 | 2026 | 6 | 0.400 |
Why?
|
| Hypoglycemic Agents | 2 | 2025 | 247 | 0.390 |
Why?
|
| Time Factors | 8 | 2026 | 989 | 0.370 |
Why?
|
| Retirement | 2 | 2026 | 6 | 0.370 |
Why?
|
| Income | 3 | 2024 | 81 | 0.360 |
Why?
|
| Cross-Sectional Studies | 10 | 2026 | 1233 | 0.330 |
Why?
|
| Memory | 3 | 2026 | 13 | 0.310 |
Why?
|
| Risk | 4 | 2021 | 453 | 0.300 |
Why?
|
| Positron-Emission Tomography | 5 | 2026 | 33 | 0.290 |
Why?
|
| C-Reactive Protein | 3 | 2017 | 52 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 5 | 0.260 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2017 | 8 | 0.260 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2017 | 9 | 0.260 |
Why?
|
| Adult Survivors of Child Adverse Events | 2 | 2018 | 4 | 0.260 |
Why?
|
| Self Report | 2 | 2020 | 248 | 0.250 |
Why?
|
| Apolipoprotein E2 | 1 | 2026 | 1 | 0.250 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2026 | 2 | 0.250 |
Why?
|
| Apolipoproteins E | 1 | 2026 | 10 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 1 | 2026 | 5 | 0.240 |
Why?
|
| Memory Disorders | 1 | 2026 | 8 | 0.240 |
Why?
|
| Psychological Trauma | 2 | 2016 | 6 | 0.240 |
Why?
|
| Occipital Lobe | 1 | 2026 | 1 | 0.240 |
Why?
|
| Cerebrovascular Disorders | 1 | 2026 | 29 | 0.240 |
Why?
|
| Triglycerides | 2 | 2025 | 78 | 0.240 |
Why?
|
| Social Networking | 1 | 2026 | 19 | 0.240 |
Why?
|
| Acute Coronary Syndrome | 1 | 2026 | 18 | 0.230 |
Why?
|
| Volunteers | 1 | 2026 | 9 | 0.230 |
Why?
|
| Divorce | 1 | 2025 | 1 | 0.230 |
Why?
|
| Social Isolation | 1 | 2026 | 20 | 0.230 |
Why?
|
| Activities of Daily Living | 1 | 2026 | 71 | 0.230 |
Why?
|
| Mortality | 1 | 2026 | 116 | 0.230 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 12 | 0.230 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2025 | 14 | 0.230 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2025 | 5 | 0.230 |
Why?
|
| Metformin | 1 | 2025 | 49 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2026 | 120 | 0.220 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 571 | 0.220 |
Why?
|
| Walking Speed | 1 | 2024 | 3 | 0.220 |
Why?
|
| Hearing Loss | 1 | 2025 | 14 | 0.220 |
Why?
|
| Cholesterol, HDL | 1 | 2025 | 64 | 0.210 |
Why?
|
| Nurses | 3 | 2019 | 32 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 1204 | 0.200 |
Why?
|
| Insurance, Health | 1 | 2025 | 167 | 0.200 |
Why?
|
| Mental Disorders | 1 | 2026 | 248 | 0.200 |
Why?
|
| Biomarkers | 5 | 2025 | 284 | 0.180 |
Why?
|
| Internal-External Control | 2 | 2020 | 10 | 0.180 |
Why?
|
| Genotype | 3 | 2026 | 198 | 0.180 |
Why?
|
| Ethnic Groups | 3 | 2021 | 418 | 0.180 |
Why?
|
| Desegregation | 1 | 2021 | 1 | 0.180 |
Why?
|
| White Matter | 3 | 2026 | 4 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 1 | 0.170 |
Why?
|
| Prevalence | 4 | 2026 | 785 | 0.170 |
Why?
|
| Child | 9 | 2023 | 2433 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2025 | 2463 | 0.170 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 26 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 13 | 0.160 |
Why?
|
| Parents | 2 | 2017 | 298 | 0.160 |
Why?
|
| Antidepressive Agents | 2 | 2019 | 140 | 0.160 |
Why?
|
| Inflammation | 2 | 2017 | 56 | 0.160 |
Why?
|
| Glycated Hemoglobin A | 2 | 2018 | 176 | 0.160 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2020 | 6 | 0.160 |
Why?
|
| Southeastern United States | 2 | 2017 | 8 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 31 | 0.160 |
Why?
|
| Social Mobility | 1 | 2019 | 2 | 0.150 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2019 | 13 | 0.150 |
Why?
|
| Hand Strength | 1 | 2019 | 12 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 445 | 0.150 |
Why?
|
| Television | 1 | 2019 | 14 | 0.150 |
Why?
|
| Walking | 1 | 2019 | 82 | 0.140 |
Why?
|
| Age Factors | 2 | 2018 | 814 | 0.140 |
Why?
|
| Independent Living | 3 | 2025 | 24 | 0.140 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 16 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 374 | 0.130 |
Why?
|
| Chronic Disease | 2 | 2017 | 382 | 0.130 |
Why?
|
| Health | 1 | 2017 | 26 | 0.130 |
Why?
|
| Telomere Shortening | 1 | 2017 | 3 | 0.130 |
Why?
|
| Psychometrics | 1 | 2017 | 114 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 5 | 0.130 |
Why?
|
| Poverty Areas | 1 | 2017 | 23 | 0.130 |
Why?
|
| Taxes | 1 | 2017 | 23 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2018 | 315 | 0.120 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 59 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2016 | 925 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 23 | 0.120 |
Why?
|
| Exercise | 2 | 2020 | 513 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 46 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 55 | 0.110 |
Why?
|
| Child Abuse | 1 | 2015 | 44 | 0.110 |
Why?
|
| Smoking | 1 | 2017 | 373 | 0.110 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 41 | 0.110 |
Why?
|
| HIV Infections | 1 | 2021 | 708 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 213 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2021 | 1430 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2023 | 278 | 0.090 |
Why?
|
| Obesity | 2 | 2016 | 811 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2017 | 702 | 0.090 |
Why?
|
| Adolescent | 6 | 2017 | 3464 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 410 | 0.090 |
Why?
|
| Comorbidity | 2 | 2026 | 516 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 173 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2009 | 8 | 0.080 |
Why?
|
| School Nursing | 1 | 2009 | 1 | 0.070 |
Why?
|
| Adiposity | 1 | 2009 | 69 | 0.070 |
Why?
|
| Reference Values | 2 | 2024 | 78 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 2456 | 0.070 |
Why?
|
| Consumer Behavior | 1 | 2009 | 27 | 0.070 |
Why?
|
| School Health Services | 1 | 2009 | 39 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2020 | 1047 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 325 | 0.070 |
Why?
|
| Prognosis | 3 | 2017 | 568 | 0.070 |
Why?
|
| Social Environment | 2 | 2021 | 77 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 117 | 0.070 |
Why?
|
| Hospitalization | 2 | 2026 | 816 | 0.070 |
Why?
|
| Health Surveys | 2 | 2019 | 226 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2026 | 1 | 0.060 |
Why?
|
| Atrophy | 1 | 2026 | 5 | 0.060 |
Why?
|
| Neuropathology | 1 | 2026 | 2 | 0.060 |
Why?
|
| Social Determinants of Health | 2 | 2020 | 39 | 0.060 |
Why?
|
| Heterozygote | 1 | 2026 | 24 | 0.060 |
Why?
|
| United Kingdom | 2 | 2016 | 24 | 0.060 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2026 | 23 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2026 | 25 | 0.060 |
Why?
|
| Denmark | 1 | 2025 | 14 | 0.060 |
Why?
|
| Leisure Activities | 1 | 2026 | 29 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2026 | 57 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2025 | 30 | 0.060 |
Why?
|
| Propensity Score | 1 | 2025 | 78 | 0.060 |
Why?
|
| Audiometry | 1 | 2025 | 2 | 0.060 |
Why?
|
| Brazil | 1 | 2025 | 7 | 0.060 |
Why?
|
| Organ Size | 1 | 2025 | 16 | 0.060 |
Why?
|
| Self-Help Devices | 1 | 2024 | 2 | 0.050 |
Why?
|
| Social Support | 1 | 2026 | 195 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2026 | 319 | 0.050 |
Why?
|
| Medicare | 1 | 2025 | 188 | 0.050 |
Why?
|
| Medicaid | 1 | 2025 | 189 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2023 | 5 | 0.050 |
Why?
|
| Death | 1 | 2023 | 10 | 0.050 |
Why?
|
| Algorithms | 1 | 2025 | 210 | 0.050 |
Why?
|
| Registries | 1 | 2025 | 449 | 0.050 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 400 | 0.050 |
Why?
|
| Insulin | 1 | 2023 | 181 | 0.050 |
Why?
|
| Life Change Events | 1 | 2021 | 26 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 45 | 0.040 |
Why?
|
| Mexico | 1 | 2020 | 16 | 0.040 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 2 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 32 | 0.040 |
Why?
|
| Psychology | 1 | 2020 | 13 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2026 | 515 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2019 | 30 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 164 | 0.040 |
Why?
|
| Pharmacoepidemiology | 1 | 2019 | 15 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2019 | 8 | 0.040 |
Why?
|
| Exposure to Violence | 1 | 2019 | 9 | 0.040 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2019 | 45 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2020 | 305 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 40 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 376 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 145 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 995 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 12 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 796 | 0.030 |
Why?
|
| New Zealand | 1 | 2017 | 7 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 9 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 26 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 100 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 8 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 11 | 0.030 |
Why?
|
| Emotions | 1 | 2015 | 32 | 0.030 |
Why?
|
| Social Adjustment | 1 | 2015 | 10 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 75 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 670 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 187 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2017 | 350 | 0.030 |
Why?
|
| Anxiety | 1 | 2015 | 154 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 294 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 828 | 0.030 |
Why?
|
| Geography, Medical | 1 | 2013 | 4 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 1212 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 302 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 8 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 32 | 0.020 |
Why?
|
| Lipids | 1 | 2009 | 66 | 0.020 |
Why?
|
| Massachusetts | 1 | 2009 | 58 | 0.020 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->